Skip to main content
OpenTrials

Clinical trial condition

Blast Crisis

Explore clinical trials studying Blast Crisis. Study availability and eligibility vary by location and protocol.

270 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Blast Crisis trial results

Recruiting

Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors

NCT03934372

Conditions
Accelerated Phase Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, +31 more
Locations
  • Ghent University Hospital Ghent, Belgium
  • Hopital Robert Debre Paris, France
  • Armand Trousseau Hospital Paris, France
  • Centre Hospitalier Universitaire de Poitiers Poitiers, France
View all 23 locations
View Trial Details
Recruiting

Asciminib Roll-over Study

NCT04877522

Conditions
Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +15 more
Locations
  • Michigan Med University of Michigan Ann Arbor, Michigan, United States
  • Memorial Sloan Kettering New York, United States
  • Oregon Health Sciences University Portland, Oregon, United States
  • Texas Oncology Dallas, Texas, United States
View all 85 locations
View Trial Details
Recruiting

Registry of Older Patients With Cancer

NCT01137825

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +98 more
Locations
  • Seby B. Jones Cancer Center Boone, North Carolina, United States
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
  • East Carolina University Greenville, North Carolina, United States
  • Pardee Cancer Center Hendersonville, North Carolina, United States
View Trial Details
Recruiting

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

NCT04260022

Conditions
B Cell Precursor Type Acute Leukemia, Blast Crisis, Bone Marrow Diseases, +35 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • Augusta Cancer Center Augusta, Georgia, United States
View Trial Details

Related conditions